Domestic supply of GSK’s meningitis, ‘Hiberix,’ suspended

‘Hiberix,’ a meningitis vaccine, has been suspended in the domestic supply.

GSK, the supplier of the drug, decided to suspend the supply of Hiberix as adopting ‘Vaxem-Hib,’ another meningitis vaccine, through the last year’s acquisition of the Novartis’s vaccine department.

‘Hiberix’ is a product which used to record KRW 10 billion sales, but has practically had difficulties in balancing the ...